Pfizer Inc. (BKK:PFIZER19)

Thailand flag Thailand · Delayed Price · Currency is THB
17.00
+0.20 (1.19%)
At close: Feb 9, 2026
Market Cap4.79T -3.6%
Revenue (ttm)1.97T -1.6%
Net Income245.07B -3.2%
EPS43.03 -3.4%
Shares Outn/a
PE Ratio19.53
Forward PE9.10
Dividend0.69 (4.04%)
Ex-Dividend DateJan 23, 2026
Volume113,170
Average Volume212,738
Open16.90
Previous Close16.80
Day's Range16.70 - 17.20
52-Week Range15.10 - 18.00
Betan/a
RSI63.38
Earnings DateFeb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange Stock Exchange of Thailand
Ticker Symbol PFIZER19
Full Company Profile

Financial Performance

In 2025, Pfizer's revenue was $62.58 billion, a decrease of -1.65% compared to the previous year's $63.63 billion. Earnings were $7.77 billion, a decrease of -3.24%.

Financial numbers in USD Financial Statements